PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

44 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
21.
Blüher, M. ; Malhotra, A.* & Bader, G.D.*: β-cell function in treatment-naïve patients with type 2 diabetes mellitus: Analyses of baseline data from 15 clinical trials. Diabetes Obes. Metab. 25, 1403-1407 (2023)
22.
Blüher, M. et al.: New insights into the treatment of obesity. Diabetes Obes. Metab. 25, 2058-2072 (2023)
23.
McGill, J.B.* et al.: Effects of finerenone in persons with CKD and T2D are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline. Diabetes Obes. Metab. 25, 1512-1522 (2023)
24.
Schultes, B.* ; Ernst, B.* ; Hallschmid, M. ; Bueter, M.* & Meyhöfer, S.M.*: The ‘Behavioral Balance Model’: A new perspective on the aetiology and therapy of obesity. Diabetes Obes. Metab. 25, 3444-3452 (2023)
25.
Wagner, L. et al.: Brain insulin responsiveness is linked to age and peripheral insulin sensitivity. Diabetes Obes. Metab. 25, 2171-2180 (2023)
26.
Hummel, J. et al.: Eight weeks of empagliflozin does not affect pancreatic fat content and insulin secretion in people with prediabetes. Diabetes Obes. Metab. 24, 1661-1666 (2022)
27.
Kiefer, L.S.* et al.: Distribution patterns of intramyocellular and extramyocellular fat by magnetic resonance imaging in subjects with diabetes, prediabetes and normoglycaemic controls. Diabetes Obes. Metab. 23, 1868–1878 (2021)
28.
Sachs, S. et al.: Plasma proteome profiles treatment efficacy of incretin dual agonism in diet-induced obese female and male mice. Diabetes Obes. Metab. 23, 195-207 (2021)
29.
Seufert, J.* et al.: Switching the basal insulin to insulin glargine 300 U/ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety. Diabetes Obes. Metab., DOI: 10.1111/dom.14549 (2021)
30.
Mathieu, C.* et al.: Benefit/risk profile of dapagliflozin 5 mg in theDEPICT-1 and-2 trials in individuals with type 1 diabetes and body mass index >= 27 kg/m(2). Diabetes Obes. Metab. 22, 2151-2160 (2020)
31.
Pfohl, M.* et al.: Effectiveness and safety of insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes after failure of oral therapy in a real-world setting. Diabetes Obes. Metab. 22, 759-766 (2020)
32.
Brede, S.* et al.: Intranasal oxytocin fails to acutely improve glucose metabolism in obese men. Diabetes Obes. Metab. 21, 424-428 (2019)
33.
Jendle, J.* et al.: Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials. Diabetes Obes. Metab., DOI: 10.1111/dom.13816 (2019)
34.
Plomgaard, P.* et al.: Nasal insulin administration does not affect hepatic glucose production at systemic fasting insulin levels. Diabetes Obes. Metab. 21, 993-1000 (2019)
35.
Kantartzis, K. et al.: Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial. Diabetes Obes. Metab. 20, 1793-1797 (2018)
36.
McCreight, L.* et al.: Pharmacokinetics of metformin in patients with gastrointestinal intolerance. Diabetes Obes. Metab. 20, 1593-1601 (2018)
37.
Schmid, V. et al.: Safety of intranasal human insulin: A review. Diabetes Obes. Metab. 20, 1563-1577 (2018)
38.
Clemmensen, C. ; Jørgensen, C.V.* ; Smajilovic, S.* & Bräuner-Osborne, H.*: Robust GLP-1 secretion by basic L-amino acids does not require the GPRC6A receptor. Diabetes Obes. Metab. 19, 599-603 (2017)
39.
Müller, A. ; Mziaut, H. ; Neukam, M. ; Knoch, K.-P. & Solimena, M.: A 4D view on insulin secretory granule turnover in the β-cell. Diabetes Obes. Metab. 19, 107-114 (2017)
40.
Klement, J.* ; Mergelkuhl, B.* ; Born, J. ; Lehnert, H.* & Hallschmid, M.: Role of γ-aminobutyric acid signalling in the attenuation of counter-regulatory hormonal responses after antecedent hypoglycaemia in healthy men. Diabetes Obes. Metab. 16, 1274-1278 (2014)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮